Literature DB >> 6275093

Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin.

P J Rottier, M C Horzinek, B A van der Zeijst.   

Abstract

We identified eight protein species in virions of mouse hepatitis virus strain A59. Based on their sizes, prosthetic groups, and locations in virions, these proteins were designated gp180/E2, gp90/E2, pp54/N, gp26.5/E1, gp25.5/E1, p24/E1, p22/X, and p14.5/Y. The positions of the last two proteins in virions are not known. Host protein synthesis in Sac(-) cells infected with mouse hepatitis virus strain A59 was inhibited, and the following novel proteins appeared: gp150, gp90, p54, gp26.5, gp25.5, p24, p22, and p14.5. Except for gp150, these polypeptides all co-electrophoresed with mouse hepatitis virus strain A59 structural proteins. In addition, all of these proteins could be immunoprecipitated with a convalescent mouse serum or a rabbit antiserum raised against purified disrupted virus. After a 15-min pulse of infected cells with radioactive amino acids at 7h postinfection, gp90 was not detected, whereas gp26.5 and gp25.5 were only labeled to a small extent. During a subsequent chase period gp150 was processed to gp90, whereas the radioactivity in gp26.5 and gp25.5 increased concomitantly with a reduction of label in p24. Tunicamycin, an antibiotic which inhibits the synthesis of glycopeptides bearing N glycosidically linked oligosaccharides, prevented the appearance of gp150 in mouse hepatitis virus strain A59-infected cells. Instead, a 110,000-dalton protein accumulated. In contrast, the syntheses of the smaller viral glycoproteins gp26.5 and gp25.5 were resistant to this drug, indicating that these glycosylations were of the O glycosidical type. Although the production of infectious virus in tunicamycin-treated cells was inhibited by more than 99%, release of noninfectious viral particles continued. An analysis of these particles revealed that they lacked the peplomeric glycoproteins gp90/E2 and gp180/E2. Obviously, although the surface projections were not essential for budding of virus particles from the cells, they were required for infectivity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275093      PMCID: PMC256635     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Phosphoproteins of murine hepatitis viruses.

Authors:  S A Stohlman; M M Lai
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

2.  Inhibition of Rous sarcoma virus replication by 2-deoxyglucose and tunicamycin: identification of an unglycosylated env gene product.

Authors:  R Stohrer; E Hunter
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

3.  Comparison of polypeptides of two strains of murine hepatitis virus.

Authors:  R Anderson; S Cheley; E Haworth-Hatherell
Journal:  Virology       Date:  1979-09       Impact factor: 3.616

4.  Effects of glucosamine, 2-deoxyglucose, and tunicamycin on glycosylation, sulfation, and assembly of influenza viral proteins.

Authors:  K Nakamura; R W Compans
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

5.  Coronavirus JHM: intracellular protein synthesis.

Authors:  S Siddell; H Wege; A Barthel; V ter Meulen
Journal:  J Gen Virol       Date:  1981-03       Impact factor: 3.891

6.  Pathogenic murine coronaviruses. II. Characterization of virus-specific proteins of murine coronaviruses JHMV and A59V.

Authors:  C W Bond; J L Leibowitz; J A Robb
Journal:  Virology       Date:  1979-04-30       Impact factor: 3.616

7.  Coronavirus JHM: cell-free synthesis of structural protein p60.

Authors:  S G Siddell; H Wege; A Barthel; V ter Meulen
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

8.  Suppression of glycoprotein formation of Semliki Forest, influenza, and avian sarcoma virus by tunicamycin.

Authors:  R T Schwarz; J M Rohrschneider; M F Schmidt
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

9.  Characterization of coronavirus II. Glycoproteins of the viral envelope: tryptic peptide analysis.

Authors:  L S Sturman; K V Holmes
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

10.  I. Structural proteins: effects of preparative conditions on the migration of protein in polyacrylamide gels.

Authors:  L S Sturman
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

View more
  102 in total

1.  Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein.

Authors:  C A de Haan; M Smeets; F Vernooij; H Vennema; P J Rottier
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Assembly of the coronavirus envelope: homotypic interactions between the M proteins.

Authors:  C A de Haan; H Vennema; P J Rottier
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Coronaviruses maintain viability despite dramatic rearrangements of the strictly conserved genome organization.

Authors:  Cornelis A M de Haan; Haukeline Volders; Cheri A Koetzner; Paul S Masters; Peter J M Rottier
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Glycosylation and oligomerization of the spike protein of Marburg virus.

Authors:  H Feldmann; C Will; M Schikore; W Slenczka; H D Klenk
Journal:  Virology       Date:  1991-05       Impact factor: 3.616

Review 6.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

7.  Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain.

Authors:  Rong Ye; Cynthia Montalto-Morrison; Paul S Masters
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Coronaviruses as vectors: position dependence of foreign gene expression.

Authors:  Cornelis A M de Haan; Linda van Genne; Jeroen N Stoop; Haukeline Volders; Peter J M Rottier
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Coronavirus multiplication: locations of genes for virion proteins on the avian infectious bronchitis virus genome.

Authors:  D F Stern; B M Sefton
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

10.  Protein synthesis in cells infected by murine hepatitis viruses JHM and A59: tryptic peptide analysis.

Authors:  C W Bond; K Anderson; J L Leibowitz
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.